SCHEMBL10048583

SCHEMBL10048583

C=C[C@H](C)C(C)(N)c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.40
CYP1A2 P05177 1/20 0.40
KCNN4 O15554 1/20 0.39
TAAR1 Q96RJ0 2/20 0.38
MAPK1 P28482 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP2C19 P33261 1/20 0.34
ALDH1A1 P00352 3/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.33
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4896201 1.00 CYP2D6 (0.40) CYP2D6CYP1A2KCNN4TAAR1MAPK1
SCHEMBL838388 1.00 CYP2D6 (0.40) CYP2D6CYP1A2KCNN4TAAR1MAPK1
SCHEMBL837837 0.81 ALDH1A1 (0.37) TAAR1ALDH1A1
SCHEMBL838387 0.81 ALDH1A1 (0.37) TAAR1ALDH1A1
SCHEMBL863182 0.81 ALDH1A1 (0.37) TAAR1ALDH1A1
SCHEMBL878960 0.81 ALDH1A1 (0.37) TAAR1ALDH1A1
SCHEMBL999658 0.76 CYP1A2 (0.52) CYP2D6CYP1A2KCNN4TAAR1MAPK1
SCHEMBL4190390 0.76 ALDH1A1 (0.38) CYP2D6CYP1A2TAAR1MAPK1MAPT
SCHEMBL13091889 0.74 CYP1A2 (0.50) CYP2D6CYP1A2KCNN4TAAR1MAPK1
SCHEMBL1751596 0.74 MAPK1 (0.46) CYP2D6CYP1A2KCNN4TAAR1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143451-B2 Reacting a ketone with an allyl boron compound anc ammonia or ammonium salt; synthons KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2012-03-27 US disclosed
US-20080139847-A1 METHODS OF PREPARING TERTIARY CARBINAMINE COMPOUNDS KANATA CHEMICAL TECHNOLOGIES INC. (CA) 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139847-A1 METHODS OF PREPARING TERTIARY CARBINAMINE COMPOUNDS INMT, CROCC, GNMT CYP2D6 2234/4885CYP1A2 528/4885KCNN4 2746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.